Kuen‐Feng Chen

5.8k total citations
100 papers, 4.9k citations indexed

About

Kuen‐Feng Chen is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kuen‐Feng Chen has authored 100 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 53 papers in Oncology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Kuen‐Feng Chen's work include Protein Tyrosine Phosphatases (27 papers), Cytokine Signaling Pathways and Interactions (23 papers) and PI3K/AKT/mTOR signaling in cancer (23 papers). Kuen‐Feng Chen is often cited by papers focused on Protein Tyrosine Phosphatases (27 papers), Cytokine Signaling Pathways and Interactions (23 papers) and PI3K/AKT/mTOR signaling in cancer (23 papers). Kuen‐Feng Chen collaborates with scholars based in Taiwan, United States and South Korea. Kuen‐Feng Chen's co-authors include Chun‐Yu Liu, Pei‐Jer Chen, Chung-Wai Shiau, Ann‐Lii Cheng, Wei‐Tien Tai, Pei‐Yi Chu, Jui-Wen Huang, Man‐Hsin Hung, Hui‐Ling Chen and Ching-Shih Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Kuen‐Feng Chen

99 papers receiving 4.8k citations

Peers

Countries citing papers authored by Kuen‐Feng Chen

Since Specialization

Citations

This map shows the geographic impact of Kuen‐Feng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuen‐Feng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuen‐Feng Chen more than expected).

Fields of papers citing papers by Kuen‐Feng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuen‐Feng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuen‐Feng Chen. The network helps show where Kuen‐Feng Chen may publish in the future.

Co-authorship network of co-authors of Kuen‐Feng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kuen‐Feng Chen. A scholar is included among the top collaborators of Kuen‐Feng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuen‐Feng Chen. Kuen‐Feng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer 2017 ·Expert Opinion on Therapeutic Targets ·Man‐Hsin Hung, Kuen‐Feng Chen	20
2	Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells 2017 ·Journal of Molecular Medicine ·Chun‐Yu Liu, Kuen‐Feng Chen, (unknown), Pei‐Yi Chu, Chun‐Teng Huang, Tzu‐Ting Huang, (unknown), Wan‐Lun Wang, Chia‐Han Lee, (unknown), (unknown), Jung-Chen Su, (unknown), Ming‐Huang Chen, Chung-Wai Shiau, Ling‐Ming Tseng	22
3	Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase 2017 ·Biochemical Pharmacology ·Yao‐Li Chen, Man‐Hsin Hung, Pei‐Yi Chu, Tzu‐I Chao, Ming‐Hsien Tsai, Li‐Ju Chen, (unknown), (unknown), Feng‐Shu Hsieh, Kuen‐Feng Chen	20
4	Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma 2016 ·Hepatology ·Wei‐Tien Tai, Yao‐Li Chen, Pei‐Yi Chu, Li‐Ju Chen, Man‐Hsin Hung, Chung‐Wai Shiau, (unknown), Ming‐Hsien Tsai, Kuen‐Feng Chen	36
5	Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma 2016 ·Scientific Reports ·Hao‐Wei Teng, Man‐Hsin Hung, (unknown), (unknown), (unknown), Ming‐Hsien Tsai, Jui-Wen Huang, Chih-Lung Lin, Hsiang‐Wen Tseng, (unknown), Jeng‐Kai Jiang, Shung-Haur Yang, Chung-Wai Shiau, Kuen‐Feng Chen	10
6	Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy 2015 ·BMC Cancer ·Kuen‐Feng Chen, Chueh‐Chuan Yen, Jen-Kou Lin, Wei-Shone Chen, Shung-Haur Yang, Jeng‐Kai Jiang, Yuan‐Tzu Lan, Chun‐Chi Lin, (unknown), (unknown), (unknown), Hao‐Wei Teng	17
7	A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy 2015 ·Cancer Letters ·(unknown), Wei‐Tien Tai, Man‐Hsin Hung, Ming‐Hsien Tsai, (unknown), (unknown), Chung-Wai Shiau, Kuen‐Feng Chen	28
8	Copper–obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinoma 2015 ·Chemico-Biological Interactions ·Jung-Chen Su, (unknown), Jui-Wen Huang, Ping‐Yu Chen, Kuen‐Feng Chen, Ping‐Hui Tseng, Chung-Wai Shiau	6
9	SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma 2015 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), Pei‐Yi Chu, (unknown), Hang Lin, Haochen Yu, Kuen‐Feng Chen	56
10	Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A 2014 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Pei‐Yi Chu, (unknown), (unknown), Chun‐Yu Liu, (unknown), Kuen‐Feng Chen	53
11	SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model 2013 ·Molecular Cancer Therapeutics ·Wei‐Tien Tai, Chung-Wai Shiau, (unknown), Yao-Li Chen, Pei‐Yi Chu, Jui-Wen Huang, (unknown), (unknown), Pei‐Jer Chen, Kuen‐Feng Chen	7
12	Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3 2012 ·Biochemical Pharmacology ·Kuen‐Feng Chen, Hui‐Ling Chen, Chun‐Yu Liu, Wei‐Tien Tai, Kimihisa Ichikawa, Pei‐Jer Chen, Ann‐Lii Cheng	41
13	A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation 2012 ·Cancer Letters ·Kuen‐Feng Chen, Jung-Chen Su, Chun‐Yu Liu, Jui-Wen Huang, (unknown), (unknown), Wei‐Tien Tai, Chung-Wai Shiau	44
14	Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma 2012 ·Biochemical Pharmacology ·(unknown), Hui-Ju Chen, Ya-Ling Chang, Chun‐Yu Liu, Chung-Wai Shiau, Ann‐Lii Cheng, Kuen‐Feng Chen	44
15	Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells 2012 ·Haematologica ·Chun‐Yu Liu, (unknown), (unknown), Hsiang–Po Huang, Ming‐Huang Chen, Cheng‐Hwai Tzeng, Kuen‐Feng Chen	40
16	Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists 2012 ·European Journal of Medicinal Chemistry ·(unknown), Kuen‐Feng Chen, Weilin Chen, Chun‐Yu Liu, (unknown), Wei‐Tien Tai, Pei‐Jer Chen, (unknown), Chung‐Wai Shiau	21
17	Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells 2012 ·Biochemical Pharmacology ·Kuen‐Feng Chen, Jing‐Ping Lin, Chung-Wai Shiau, Wei‐Tien Tai, Chun‐Yu Liu, (unknown), Pei‐Jer Chen, Ann‐Lii Cheng	51
18	Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity 2012 ·Bioorganic & Medicinal Chemistry ·Kuen‐Feng Chen, (unknown), Jung-Chen Su, (unknown), Chun‐Yu Liu, Hui-Ju Chen, Jui-Wen Huang, Inki Kim, Chung-Wai Shiau	35
19	Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells 2010 ·Cancer Research ·Da‐Liang Ou, Ying‐Chun Shen, Sung‐Liang Yu, Kuen‐Feng Chen, (unknown), (unknown), Wen-Chi Feng, (unknown), Liang‐In Lin, Chiun Hsu, Ann‐Lii Cheng	68
20	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells 2010 ·Oncogene ·Kuen‐Feng Chen, Chun‐Yu Liu, (unknown), (unknown), Tsung‐Hao Liu, Duen‐Ren Hou, Pei‐Jer Chen, Ann‐Lii Cheng	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact